Hudson H Freeze Selected Research

Congenital Disorders of Glycosylation

11/2022	Chemical Therapies for Congenital Disorders of Glycosylation.
7/2022	Clinical, biochemical and genetic characteristics of MOGS-CDG: a rare congenital disorder of glycosylation.
1/2022	ALG8-CDG: Molecular and phenotypic expansion suggests clinical management guidelines.
1/2021	Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDG.
1/2019	Arrest of Fetal Brain Development in ALG11-Congenital Disorder of Glycosylation.
1/2018	Perspectives on Glycosylation and Its Congenital Disorders.
1/2018	Glycosyltransferase genes that cause monogenic congenital disorders of glycosylation are distinct from glycosyltransferase genes associated with complex diseases.
11/2017	Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1.
1/2017	Dissecting the molecular organization of the translocon-associated protein complex.
1/2016	Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hudson H Freeze Research Topics

Disease

34	Congenital Disorders of Glycosylation 11/2022 - 03/2002
21	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2021 - 03/2002
9	Neoplasms (Cancer) 01/2020 - 05/2008
7	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 07/2006
6	Inflammation (Inflammations) 01/2021 - 10/2005
6	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 02/2009 - 05/2005
5	Liver Diseases (Liver Disease) 01/2021 - 02/2006
5	Microcephaly 01/2019 - 07/2007
3	Seizures (Absence Seizure) 01/2019 - 07/2007
3	Muscle Hypotonia (Hypotonia) 11/2013 - 01/2005
2	Brain Diseases (Brain Disorder) 03/2022 - 11/2017
2	Alacrima 12/2019 - 10/2014
2	NGLY1 deficiency 01/2018 - 08/2015
2	Fatty Liver 01/2018 - 04/2016
2	Growth Disorders 01/2016 - 04/2014
2	Hypoglycemia (Reactive Hypoglycemia) 04/2014 - 06/2007
2	Muscular Dystrophies (Muscular Dystrophy) 11/2013 - 08/2003
2	Glioma (Gliomas) 06/2010 - 05/2008
2	Carcinogenesis 07/2009 - 10/2008
2	Colitis 10/2008 - 10/2005
2	Hypertension (High Blood Pressure) 01/2008 - 03/2006
2	Failure to Thrive 07/2007 - 01/2005
2	Crohn Disease (Crohn's Disease) 04/2006 - 10/2005
1	Neutropenia 01/2021
1	Atherosclerosis 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Spasm (Spasms) 11/2020
1	Epilepsy (Aura) 11/2020
1	Portal Hypertension 11/2020
1	congenital Sucrase-isomaltase deficiency 01/2020
1	Epstein-Barr Virus Infections 01/2020
1	Cone-Rod Dystrophies 01/2020
1	Intellectual Disability (Idiocy) 01/2019
1	Hyperpigmentation 01/2018
1	Obesity 01/2018
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2018
1	Dowling-Degos Disease 01/2018
1	Weight Gain 01/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 08/2016

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2002
14	Polysaccharides (Glycans)IBA 01/2022 - 03/2002
12	Glycoproteins (Glycoprotein)IBA 01/2022 - 08/2003
11	Mannose (D-Mannose)IBA 01/2021 - 03/2006
8	LipidsIBA 01/2019 - 12/2002
8	Transferrin (beta 2 Transferrin)IBA 01/2017 - 05/2004
6	phosphomannomutaseIBA 01/2016 - 03/2002
6	Mannose-6-Phosphate Isomerase (Mannose 6 Phosphate Isomerase)IBA 04/2014 - 01/2003
5	Blood Proteins (Serum Proteins)IBA 08/2016 - 05/2005
4	OligosaccharidesIBA 01/2018 - 12/2002
4	EnzymesIBA 02/2015 - 01/2003
3	GlycolipidsIBA 01/2022 - 01/2019
3	Transaminases (Aminotransferases)IBA 01/2020 - 10/2014
3	NucleotidesIBA 01/2020 - 09/2011
3	MonosaccharidesIBA 01/2020 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2014
3	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 02/2009 - 05/2005
3	NF-kappa B (NF-kB)IBA 10/2008 - 10/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008 - 05/2005
2	AntibodiesIBA 01/2021 - 11/2013
2	AcidsIBA 01/2021 - 01/2020
2	UDP-galactose translocatorIBA 01/2019 - 04/2013
2	signal sequence receptorIBA 01/2019 - 03/2014
2	FucoseIBA 01/2018 - 12/2015
2	GlycosyltransferasesIBA 01/2018 - 02/2015
2	Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseIBA 01/2018 - 08/2015
2	SugarsIBA 11/2017 - 09/2011
2	Congenital disorder of glycosylation type 1AIBA 01/2016 - 01/2016
2	Phosphates (Orthophosphate)IBA 01/2016 - 08/2003
2	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2015 - 04/2012
2	Dystroglycans (Dystroglycan)IBA 11/2013 - 08/2003
2	CarbohydratesIBA 11/2013 - 10/2005
2	mannose-6-phosphateIBA 01/2013 - 11/2012
2	Heparitin Sulfate (Heparan Sulfate)IBA 03/2006 - 05/2005
2	TransferasesIBA 08/2003 - 03/2002
1	glucosidase IIBA 07/2022
1	Uridine Monophosphate (UMP)IBA 03/2022
1	GlycogenIBA 01/2021
1	N-glycolylneuraminic acidIBA 01/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2021
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2020
1	Felbamate (Felbatol)FDA Link 11/2020
1	Clobazam (HR 376)IBA 11/2020
1	Prednisolone (Predate)FDA LinkGeneric 11/2020
1	Sodium-Hydrogen ExchangersIBA 01/2020
1	MagnesiumIBA 01/2020
1	Aquaporins (Water Channels)IBA 12/2019
1	carbohydrate-deficient transferrinIBA 01/2019
1	von Willebrand FactorIBA 01/2019
1	Factor VIII (Coagulation Factor VIII)IBA 01/2019
1	fucokinaseIBA 12/2018
1	Alkaline PhosphataseIBA 10/2018
1	CholesterolIBA 10/2018
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2018
1	FucosyltransferasesIBA 01/2018
1	Cytidine Monophosphate N-Acetylneuraminic AcidIBA 11/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	TRAPP transport protein particleIBA 04/2016
1	AsparagineIBA 01/2016
1	IsomerasesIBA 01/2016

Therapy/Procedure

6	Therapeutics 11/2022 - 04/2008